• AICAR Phosphate (Acadesine): AMPK Activation and B-CLL Apopt

  2026-07-21

  AICAR phosphate (Acadesine) is a potent AMPK activator that triggers apoptosis in B-cell chronic lymphocytic leukemia (B-CLL) cells by inducing caspase activation and mitochondrial cytochrome c release. It demonstrates selective cytotoxicity toward B cells, sparing T cells at defined concentrations. The reagent’s high solubility and rigorous QC make it ideal for reproducible research workflows.

• Cyclo (-RGDfC): Benchmark Cyclic RGD Peptide for αvβ3 Target

  2026-07-21

  Cyclo (-RGDfC) is a cyclic peptide engineered for high-affinity, selective targeting of the integrin αvβ3 receptor, a key mediator in tumor angiogenesis and metastasis. Its cyclic structure yields enhanced stability and specificity compared to linear RGD peptides, making it a foundational tool for integrin-mediated cell adhesion and cancer research.

• AI-Driven Discovery of Senolytics: Insights and Experimental

  2026-07-20

  This article examines how machine learning enabled the discovery of novel senolytic compounds targeting senescent cells, as reported in a recent Nature Communications study. The approach reduces drug screening costs and highlights new opportunities for translational research, including the identification of cardiac glycosides as potent, selective Na+/K+-ATPase inhibitors with senolytic activity.

• Dual DNMT and Tubulin Inhibition: H62 Blocks Erythroleukemia

  2026-07-20

  The referenced study introduces H62, a novel letermovir derivative that uniquely targets both β-tubulin and DNA methyltransferase 1 (DNMT1), demonstrating potent anti-leukemic effects in erythroleukemia models. This dual mechanism induces cell cycle arrest, erythroid differentiation, and apoptosis, offering a promising direction for treating aggressive leukemias resistant to conventional therapies.

• PF-573228: Advanced FAK Inhibitor Protocols for Mechanotrans

  2026-07-19

  PF-573228 stands out as a potent FAK inhibitor, enabling precision dissection of cell adhesion, migration, and mechanotransduction—especially in dental and angiogenesis models. This article translates cutting-edge experimental findings into actionable workflows, troubleshooting guidance, and strategic assay enhancements for researchers leveraging PF-573228 from APExBIO.

• PD 173074: Selective FGFR1/VEGFR2 Inhibitor for Angiogenesis

  2026-07-18

  PD 173074 is a potent, selective ATP-competitive inhibitor of FGFR1 and VEGFR2, widely used in cancer and angiogenesis research. Its nanomolar efficacy and high selectivity profile make it a benchmark molecule for dissecting FGFR signaling and overcoming drug resistance. This article provides protocol details, evidence-based benchmarks, and clarifies misconceptions to support reproducible results.

• Applied Uses of JNJ-26854165 (Serdemetan) in Cancer Research

  2026-07-17

  JNJ-26854165 (Serdemetan) empowers researchers with a robust, HDM2-targeted approach to p53 pathway modulation, enabling advanced anti-proliferative and radiosensitization studies. This guide translates bench-proven protocols and troubleshooting insights into actionable workflows, ensuring reliable, reproducible results in cancer biology.

• 3-Bromopyruvate and Cetuximab Synergy: Overcoming CRC Resist

  2026-07-17

  This study demonstrates that 3-bromopyruvate, in combination with cetuximab, restores sensitivity in cetuximab-resistant colorectal cancer (CRC) cells by inducing autophagy-dependent ferroptosis through modulation of FOXO3a signaling. The findings highlight a mechanistic strategy to counteract resistance in KRAS/BRAF mutant and acquired-resistant CRC, with translational implications for ferroptosis-targeted cancer therapies.

• Okadaic Acid: Technical Guidance for Protein Phosphatase 1 I

  2026-07-16

  Okadaic acid is a potent inhibitor for dissecting serine/threonine phosphatase function, enabling detailed study of phosphorylation-dependent signaling and cell apoptosis induction. It is best suited for targeted workflows in apoptosis, signal transduction, and cancer research, but requires careful handling and strict protocol adherence to avoid off-target effects.

• NVP-BGJ398 Phosphate: Mechanistic Insights and Protocols for

  2026-07-16

  Explore the molecular mechanisms and advanced assay strategies for NVP-BGJ398 phosphate, a leading FGFR inhibitor. This article uniquely analyzes translational insights, protocol parameters, and scientific depth beyond skeletal models.

• Leupeptin, Microbial (Leupeptin hemisulfate): Reliable Prote

  2026-07-15

  This article explores scenario-driven challenges in cell viability, proliferation, and cytotoxicity assays, demonstrating how Leupeptin, Microbial (Leupeptin hemisulfate) (SKU A2570) from APExBIO offers reproducible, data-backed solutions. Through evidence-based Q&As, it addresses protease activity regulation, protocol optimization, and vendor selection, equipping biomedical researchers with actionable insights for robust experimental workflows.

• Vincristine Sulfate: Mechanisms, Benchmarks, and Workflow In

  2026-07-15

  Vincristine sulfate is a potent tubulin polymerization inhibitor used in cancer research for its microtubule-disrupting and antiproliferative actions. The compound demonstrates nanomolar efficacy in vitro and robust tumor growth delay in vivo. Its validated solubility and storage workflow make it a reliable choice for translational oncology applications.

• Leveraging JNJ-26854165 (Serdemetan) for Precision p53 Pathw

  2026-07-14

  JNJ-26854165 (Serdemetan) empowers cancer researchers to dissect HDM2-p53 dynamics with reproducible, quantitative precision. This article details experimental workflows, troubleshooting insights, and unique advantages for advanced anti-proliferative and radiosensitization studies.

• KNUCKLES Orchestrates Hormonal Control of Floral Meristem Te

  2026-07-14

  The reference study uncovers how the KNUCKLES (KNU) zinc finger protein coordinates floral meristem termination in Arabidopsis by integrating auxin and cytokinin regulation. This work elucidates the direct, epigenetic repression of key hormonal genes, refining the molecular understanding of plant reproductive development and offering a framework for future research.

• JHU-083: Applied Protocols in Glutaminase Pathway Research

  2026-07-13

  JHU-083, a potent 6-diazo-5-oxo-L-norleucine precursor, empowers researchers to precisely inhibit glutaminase activity in experimental cerebral malaria and neurological disease models. This article delivers hands-on protocols, troubleshooting strategies, and cross-domain insights, leveraging APExBIO's high-purity compound for reproducible, high-impact results.

11244 records 1/750 page Next 12345 下5页 Last page